Dyslipidemia and maternal obesity: Prematurity and neonatal prognosis

Iramar Baptistella do Nascimento1, Guilherme Dienstmann1, Matheus Leite Ramos de Souza2

  • 1Department of Graduate Studies in Health and the Environment, Universidade da Região de Joinville, Joinville, SC, Brazil.

Revista Da Associacao Medica Brasileira (1992)
|April 12, 2018
PubMed

Insights

Obesity and dyslipidemia in pregnancy can lead to preterm birth and impact newborn health. These conditions increase the risk of epicardial fat in preterm infants, affecting them long-term.

Area of Science:

  • Reproductive Medicine
  • Metabolic Disorders
  • Neonatal Health

Background:

  • Obesity and dyslipidemia are significant concerns during pregnancy.
  • These conditions can alter maternal metabolic adaptation and fetal development.

Purpose of the Study:

  • To investigate the link between maternal dyslipidemia, obesity, and preterm birth.
  • To understand the impact on newborn prognosis, specifically epicardial fat accumulation.

Main Methods:

  • A systematic review of studies published between 1996 and 2016.
  • Searches were conducted in Medline, Lilacs, Embase, and Cochrane Library using keywords: dyslipidemia, pregnancy, obesity, preterm birth.

Main Results:

  • 32 studies were included, analyzing risk factors, metabolic alterations, and dyslipidemic complications.
  • Findings indicate impaired maternal metabolic adaptation and increased lipid transfer to the fetus.

Conclusions:

  • Maternal dyslipidemia and obesity are associated with preterm birth.
  • Preterm infants born to dyslipidemic mothers face an elevated risk of developing epicardial fat in early and later life.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
296
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
194
Crossing Over01:34

Crossing Over

Unlike mitosis, meiosis aims for genetic diversity in its creation of haploid gametes. Dividing germ cells first begin this process in prophase I, where each chromosome—replicated in S phase—is now composed of two sister chromatids (identical copies) joined centrally.
The homologous pairs of sister chromosomes—one from the maternal and one from the paternal genome—then begin to align alongside each other lengthwise, matching corresponding DNA positions in a process...
172.3K
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
70.0K